RemSleep seeks OTCQB status
By HME News Staff
Updated 9:03 AM CDT, Tue June 14, 2022
TAMPA, Fla. – RemSleep has officially filed its application for OTCQB status with otcmarkets.com and expects to receive a decision in about three to four weeks. The company believes the move to the OTCQB will provide enhanced investor benefits, including higher reporting standards, greater access to analyst coverage and news outlets, and more comprehensive compliance requirements. The U.S. Securities and Exchange Commission considers the OTCQB an “established public market” for determining the public market price when registering securities for resale with the SEC. "Uplisting to the OTCQB will assist our company in providing greater shareholder value by allowing us to achieve greater market visibility, expand our potential prospective investor pool, greater share price stability, along with increased trading liquidity within the investment community,” said Tom Wood, RemSleep CEO. “We look forward to broadening our company exposure to a larger and more diverse demographic of both domestic and international investors.” OTC Markets Group operates financial markets for 11,000 U.S. and global securities. It organizes these securities into three markets based on the quality and timeliness of information a company provides to investors: the OTCQX Best Market, the OTCQB Venture Market, and the Pink Open Market.
Comments